Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Myocardial Infarction | Research article

LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93

Authors: Jing Lv, Yi Zhu, Shanglong Yao

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Myocardial infarction (MI) affects the expression of a large number of lncRNAs, while the functions of those dysregulated lncRNAs are mostly unclear.

Materials and methods

Expression of MORT and miR-93 in hearth tissues and plasma of both MI mice and Sham mice and both MI patients and healthy controls was detected by RT-qPCR. Correlations of expression levels of MORT and miR-93 between hear tissues and plasma of MI mice were explored by performing linear regression.

Results

In the present study we found that MORT expression levels were higher, while expression levels of miR-93 were lower in both plasma and heart tissues of mice MI mice models compared with Sham mice. Plasma levels of MORT and miR-93 were largely consistent with expression levels of MORT and miR-93 in heart tissue of MI mice. MORT expression levels were also higher, while levels of miR-93 were also lower in plasma of MI patients compared with healthy controls. MORT and miR-93 were inversely correlated in MI patients but not in healthy controls. MORT overexpression resulted in inhibited miR-93 expression in cardiomyocytes (AC16 cell line), while miR-93 overexpression did not significantly affect MORT expression. MORT overexpression promoted cardiomyocyte apoptosis, while miR-93 overexpression played and opposite role and attenuated the effects of MORT overexpression.

Conclusion

Therefore, lncRNA MORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93.
Literature
1.
go back to reference Maass, P. G., Luft, F. C. & Bahring, S. Long non-coding RNA in health and disease. J Mol Med (Berl), 2014, 92:337–346. Maass, P. G., Luft, F. C. & Bahring, S. Long non-coding RNA in health and disease. J Mol Med (Berl), 2014, 92:337–346.
2.
go back to reference Roberts TC, Morris KV, Weinberg MS. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs. Epigenetics. 2014;9:13–20.CrossRef Roberts TC, Morris KV, Weinberg MS. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs. Epigenetics. 2014;9:13–20.CrossRef
3.
go back to reference Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression [J]. Nat Rev Mol Cell Biol. 2016;17(12):756–70.CrossRef Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression [J]. Nat Rev Mol Cell Biol. 2016;17(12):756–70.CrossRef
4.
go back to reference Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function [J]. Nat Rev Genet. 2016;17(1):47–62.CrossRef Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function [J]. Nat Rev Genet. 2016;17(1):47–62.CrossRef
5.
go back to reference Chen X, Yan CC, Zhang X, et al. Long non-coding RNAs and complex diseases: from experimental results to computational models [J]. Brief Bioinform. 2016;18(4):558–76.PubMedCentral Chen X, Yan CC, Zhang X, et al. Long non-coding RNAs and complex diseases: from experimental results to computational models [J]. Brief Bioinform. 2016;18(4):558–76.PubMedCentral
6.
go back to reference Chandra Gupta S, Nandan TY. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets [J]. Int J Cancer. 2017;140(9):1955–67.CrossRef Chandra Gupta S, Nandan TY. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets [J]. Int J Cancer. 2017;140(9):1955–67.CrossRef
7.
go back to reference Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways [J]. Cancer Cell. 2016;29(4):452–63.CrossRef Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways [J]. Cancer Cell. 2016;29(4):452–63.CrossRef
8.
go back to reference Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197–210.CrossRef Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197–210.CrossRef
9.
go back to reference Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.CrossRef Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.CrossRef
10.
go back to reference Wolf D, Stachon P, Bode C, Zirlik A. Inflammatory mechanisms in atherosclerosis. Hamostaseologie. 2014;34(1):63–71.CrossRef Wolf D, Stachon P, Bode C, Zirlik A. Inflammatory mechanisms in atherosclerosis. Hamostaseologie. 2014;34(1):63–71.CrossRef
11.
go back to reference White HD, Chew DP. Acute myocardial infarction. Lancet. 2008;372(9638):570–84.CrossRef White HD, Chew DP. Acute myocardial infarction. Lancet. 2008;372(9638):570–84.CrossRef
12.
go back to reference Liao J, He Q, Li M, et al. LncRNA MIAT: myocardial infarction associated and more. Gene. 2016;578(2):158–61.CrossRef Liao J, He Q, Li M, et al. LncRNA MIAT: myocardial infarction associated and more. Gene. 2016;578(2):158–61.CrossRef
13.
go back to reference Li J, Sun D, Li Y. Novel findings and therapeutic targets on Cardioprotection of ischemia/reperfusion injury in STEMI. Curr Pharm Des. 2019;25(35):3726–39.CrossRef Li J, Sun D, Li Y. Novel findings and therapeutic targets on Cardioprotection of ischemia/reperfusion injury in STEMI. Curr Pharm Des. 2019;25(35):3726–39.CrossRef
14.
go back to reference Vrba L, Futscher B W. Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types [J]. F1000Research, 2018, 7. Vrba L, Futscher B W. Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types [J]. F1000Research, 2018, 7.
15.
go back to reference Ke ZP, Xu P, Shi Y, et al. MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN [J]. Oncotarget. 2016;7(20):28796–805.CrossRef Ke ZP, Xu P, Shi Y, et al. MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN [J]. Oncotarget. 2016;7(20):28796–805.CrossRef
16.
go back to reference Kolk M V V, Meyberg D, Deuse T, et al. LAD-ligation: a murine model of myocardial infarction [J]. J Vis Exp. 2009, 14;(32). Kolk M V V, Meyberg D, Deuse T, et al. LAD-ligation: a murine model of myocardial infarction [J]. J Vis Exp. 2009, 14;(32).
17.
go back to reference Wang J, Bo H, Meng X, et al. A simple and fast experimental model of myocardial infarction in the mouse. Tex Heart Inst J. 2006;33(3):290–3.PubMedPubMedCentral Wang J, Bo H, Meng X, et al. A simple and fast experimental model of myocardial infarction in the mouse. Tex Heart Inst J. 2006;33(3):290–3.PubMedPubMedCentral
18.
go back to reference Tsoi LC, Iyer MK, Stuart PE, et al. Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin [J]. Genome Biol. 2015;16(1):24.CrossRef Tsoi LC, Iyer MK, Stuart PE, et al. Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin [J]. Genome Biol. 2015;16(1):24.CrossRef
19.
go back to reference Kazemzadeh M, Safaralizadeh R, Orang AV. LncRNAs: emerging players in gene regulation and disease pathogenesis [J]. J Genet. 2015;94.CrossRef Kazemzadeh M, Safaralizadeh R, Orang AV. LncRNAs: emerging players in gene regulation and disease pathogenesis [J]. J Genet. 2015;94.CrossRef
20.
go back to reference Liu CY, Zhang YH, Li RB, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9(1):29.CrossRef Liu CY, Zhang YH, Li RB, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9(1):29.CrossRef
21.
go back to reference Liu H, Fang L, Cheng Y, et al. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. Cancer Med. 2016;5(12):3512–9.CrossRef Liu H, Fang L, Cheng Y, et al. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. Cancer Med. 2016;5(12):3512–9.CrossRef
Metadata
Title
LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93
Authors
Jing Lv
Yi Zhu
Shanglong Yao
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01522-0

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue